Simplex Trading
ANIP icon

Simplex Trading’s ANI Pharmaceuticals ANIP Stock Holding History

Simplex Trading’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.8K Buy
+400
New +$31.2K ﹤0.01% 6360
2025
Q3 		– Sell
-400
Closed -$26K – 8985
2025
Q2 		$26K Sell
400
-200
-33% -$13K ﹤0.01% 6520
2025
Q1 		$40K Buy
+600
New +$35.8K ﹤0.01% 5990
2024
Q4 		– Sell
-100
Closed -$5K – 8426
2024
Q3 		$5K Sell
100
-25,600
-100% -$1.56M ﹤0.01% 7572
2024
Q2 		$1.64M Buy
25,700
+3,100
+14% +$201K ﹤0.01% 2395
2024
Q1 		$1.56M Buy
22,600
+21,200
+1,514% +$1.28M ﹤0.01% 2652
2023
Q4 		$77K Sell
1,400
-2,900
-67% -$160K ﹤0.01% 5630
2023
Q3 		$249K Buy
4,300
+2,900
+207% +$167K ﹤0.01% 4122
2023
Q2 		$75K Buy
1,400
+900
+180% +$39.9K ﹤0.01% 5402
2023
Q1 		$19K Sell
500
-600
-55% -$25.3K ﹤0.01% 6943
2022
Q4 		$44K Sell
1,100
-900
-45% -$33.8K ﹤0.01% 6028
2022
Q3 		$64K Sell
2,000
-3,100
-61% -$106K ﹤0.01% 6089
2022
Q2 		$151K Sell
5,100
-900
-15% -$26K ﹤0.01% 4992
2022
Q1 		$168K Buy
6,000
+3,200
+114% +$119K ﹤0.01% 5397
2021
Q4 		$129K Buy
2,800
+1,800
+180% +$77.3K ﹤0.01% 5842
2021
Q3 		$35K Hold
1,000
– – ﹤0.01% 7939
2021
Q2 		$35K Buy
1,000
+989
+8,991% +$33.6K ﹤0.01% 8067
2021
Q1 		$39K Sell
11
-13
-54% -$407 ﹤0.01% 6874
2020
Q4 		$69K Sell
24
-33
-58% -$945 ﹤0.01% 5822
2020
Q3 		$160K Buy
57
+48
+533% +$1.43K ﹤0.01% 4369
2020
Q2 		$29K Sell
9
-24
-73% -$861 ﹤0.01% 5932
2020
Q1 		$134K Buy
33
+15
+83% +$798 ﹤0.01% 4055
2019
Q4 		$111K Sell
18
-37
-67% -$2.45K ﹤0.01% 4411
2019
Q3 		$400K Buy
55
+45
+450% +$3.37K ﹤0.01% 2837
2019
Q2 		$82K Sell
10
-14
-58% -$996 ﹤0.01% 4383
2019
Q1 		$169K Buy
24
+21
+700% +$1.24K ﹤0.01% 3785
2018
Q4 		$13K Sell
3
-72
-96% -$3.77K ﹤0.01% 5651
2018
Q3 		$424K Buy
75
+27
+56% +$1.65K ﹤0.01% 2806
2018
Q2 		$320K Buy
48
+17
+55% +$1.06K ﹤0.01% 2938
2018
Q1 		$20K Buy
31
+1
+3% +$63 ﹤0.01% 3338
2017
Q4 		$35K Buy
30
+7
+30% +$435 ﹤0.01% 2763
2017
Q3 		$20K Buy
23
+4
+21% +$191 ﹤0.01% 3140
2017
Q2 		$4K Sell
19
-54
-74% -$2.6K ﹤0.01% 4716
2017
Q1 		$26K Sell
73
-128
-64% -$7.19K ﹤0.01% 2979
2016
Q4 		$52K Buy
201
+61
+44% +$3.73K ﹤0.01% 2112
2016
Q3 		$91K Sell
140
-101
-42% -$6.32K 0.01% 1591
2016
Q2 		$94K Buy
+241
New +$11.7K 0.01% 1518
2016
Q1 		– Sell
-231
Closed -$51K – 5519
2015
Q4 		$51K Buy
231
+174
+305% +$7.49K ﹤0.01% 1891
2015
Q3 		$3K Buy
57
+27
+90% +$1.54K ﹤0.01% 4315
2015
Q2 		$6K Sell
30
-1
-3% -$60 ﹤0.01% 3476
2015
Q1 		$35K Buy
+31
New +$1.89K ﹤0.01% 1822

Other funds holding ANIP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Simplex Trading's ANIP Position: Q1 2026 in Review

Simplex Trading reduced its ANI Pharmaceuticals (ANIP) stake by 17% in Q1 2026, selling an estimated $54.1K and leaving 3,459 shares worth $266K. The position accounts for ﹤0.01% of the portfolio, ranked #3952.

Simplex Trading first reported a position in ANIP in Q3 2015 and has held it in 24 quarters since. The position peaked at $882K in Q3 2019. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Simplex Trading held 3,459 shares of ANI Pharmaceuticals worth $266K as of Q1 2026.
  • Simplex Trading sold 693 ANI Pharmaceuticals shares in Q1 2026, an estimated $54.1K.
  • ANI Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #3952 holding.
  • Simplex Trading first reported a position in ANI Pharmaceuticals in Q3 2015 and has held it in 24 quarters since.
  • Simplex Trading's ANI Pharmaceuticals position peaked at $882K in Q3 2019.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.